SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GZTC
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
752 28 0 GZTC
Emcee:  Barbara Bullard Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
477 News: GZTC Cancer Vaccine Produces Tumor-Specific Immune Response... biz.yahoCytokine1-12/8/1997
476 Steve; Could you expain GZTC's patent position relative to the other two coSteve Lokness-11/23/1997
475 GZTC and two other companies -- PPL in Scotland and Pharming in the NetherlandsSteve Push-11/22/1997
474 GZTC is getting cheap these last few days. Earnings will tell the tale. I keep Robert Jensen-11/20/1997
473 Cell culture is effectively limited in the supplies it can produce, because of Steve Push-11/14/1997
472 Cell culture can produce unlimited supply, but is it appropriately glycosalatedRobert Jensen-11/13/1997
471 Thanks a lot, Steve.Andrew H-11/13/1997
470 Here are the answers to the questions you posed a few weeks ago regarding the BSteve Push-11/13/1997
469 To add to my prior posts: GZTC's prospectus mentions a license for microinjBulbaMan-11/10/1997
468 Although I've been told by someone I trust the royalty rates CRLS has negotBulbaMan-11/9/1997
467 Marty, do you know what the royalty rate is on the DNA Microinjection technologVector1-11/9/1997
466 Transgenic technology followers/investors might want to check out Chrysalis BulbaMan-11/6/1997
465 Paine Webber reiterated its buy on the stock today increasing the target to 18-Vector1-11/4/1997
464 Warner-Lambert's Rezulin causes liver failure in ome cases... Looks like GZGiuseppe Scalamogna-11/4/1997
463 Imagine that! The next famine-causing locust swarms in East Africa gobbled up aCYBERKEN-11/4/1997
462 dbuki, very interesting post. Maybe GZTC will get involved with the bugs. CouldAndrew H-11/3/1997
461 Current (Nov. 17) issue of Forbes. Michael Gianturco's irregular tech columdbuki-11/3/1997
460 My pleasure Brian, In regards to today's close...it was good to see some sGiuseppe Scalamogna-10/28/1997
459 Guiseppe, Thanks for the TA ... as always. BrianMeridian-10/28/1997
458 The market is up nicely in early trading, but what is this doing to biotech? ObGiuseppe Scalamogna-10/28/1997
457 hang seng down 14% this morning... doesn't bode well.Skeeter Bug-10/28/1997
456 Hi Brian, Interesting to say the least! It's really tough to gauge what wiGiuseppe Scalamogna-10/27/1997
455 Hey Giuseppe, Interesting price action today! What do the tea leaves tell youMeridian-10/27/1997
454 Genetic Engineering News, most recent issue dated October 15, contains two artidbuki-10/25/1997
453 To all, better news in 10/23's 1hr+ conference call than in 3rd qtr report.Howard Williams-10/24/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News